×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
PTCT – ptc therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
PTCT
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/26
05:49 am
ptct
PTC Therapeutics (PTCT) was upgraded by Truist Financial Corporation to "strong-buy".
Low
Report
PTC Therapeutics (PTCT) was upgraded by Truist Financial Corporation to "strong-buy".
3/25
08:30 am
ptct
PTC Therapeutics Appoints Biotech Banking Pioneer Jessica Chutter to Board of Directors
Low
Report
PTC Therapeutics Appoints Biotech Banking Pioneer Jessica Chutter to Board of Directors
3/20
07:25 am
ptct
Assessing PTC Therapeutics (PTCT) Valuation As Rare Disease Growth And Sephience Execution Shape Expectations [Yahoo! Finance]
Low
Report
Assessing PTC Therapeutics (PTCT) Valuation As Rare Disease Growth And Sephience Execution Shape Expectations [Yahoo! Finance]
3/13
04:30 pm
ptct
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3/11
10:52 am
ptct
PTC Therapeutics, Inc. (PTCT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
Low
Report
PTC Therapeutics, Inc. (PTCT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
3/10
09:07 pm
ptct
PTC Therapeutics, Inc. (PTCT) Presents at Leerink Global Healthcare Conference 2026 Transcript [Seeking Alpha]
Medium
Report
PTC Therapeutics, Inc. (PTCT) Presents at Leerink Global Healthcare Conference 2026 Transcript [Seeking Alpha]
3/3
10:31 am
ptct
Investment Manager Bets Big on PTCT Stock, Adds 41,000 Shares, According to Recent SEC Filing [Yahoo! Finance]
Low
Report
Investment Manager Bets Big on PTCT Stock, Adds 41,000 Shares, According to Recent SEC Filing [Yahoo! Finance]
2/27
04:09 am
ptct
Global Ferroptosis Targeting Therapy Market Opportunity Report 2026: Therapeutic Approaches, Technology Development Platforms & Clinical Trials Insights By Company, Country, Indication & Phase [Yahoo! Finance]
Low
Report
Global Ferroptosis Targeting Therapy Market Opportunity Report 2026: Therapeutic Approaches, Technology Development Platforms & Clinical Trials Insights By Company, Country, Indication & Phase [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/27
11:34 am
ptct
Form SCHEDULE 13G/A PTC THERAPEUTICS, INC. Filed by: VANGUARD GROUP INC
Low
Report
Form SCHEDULE 13G/A PTC THERAPEUTICS, INC. Filed by: VANGUARD GROUP INC
3/26
07:41 pm
ptct
Form 4 PTC THERAPEUTICS, INC. For: Mar 24 Filed by: Chutter Jessica Caroline
Low
Report
Form 4 PTC THERAPEUTICS, INC. For: Mar 24 Filed by: Chutter Jessica Caroline
3/26
07:40 pm
ptct
Form 3 PTC THERAPEUTICS, INC. For: Mar 24 Filed by: Chutter Jessica Caroline
Low
Report
Form 3 PTC THERAPEUTICS, INC. For: Mar 24 Filed by: Chutter Jessica Caroline
3/25
09:01 am
ptct
Form 8-K PTC THERAPEUTICS, INC. For: Mar 24
Low
Report
Form 8-K PTC THERAPEUTICS, INC. For: Mar 24
3/13
05:20 pm
ptct
Form 4 PTC THERAPEUTICS, INC. For: Mar 11 Filed by: Klein Matthew B.
Medium
Report
Form 4 PTC THERAPEUTICS, INC. For: Mar 11 Filed by: Klein Matthew B.
3/12
05:20 pm
ptct
Form 4 PTC THERAPEUTICS, INC. For: Mar 10 Filed by: Okey Stephanie
Low
Report
Form 4 PTC THERAPEUTICS, INC. For: Mar 10 Filed by: Okey Stephanie
3/12
03:24 pm
ptct
Form 144 PTC THERAPEUTICS, INC. Filed by: Klein Matthew B.
Low
Report
Form 144 PTC THERAPEUTICS, INC. Filed by: Klein Matthew B.
3/10
02:13 pm
ptct
Form 144 PTC THERAPEUTICS, INC. Filed by: Okey Stephanie
Low
Report
Form 144 PTC THERAPEUTICS, INC. Filed by: Okey Stephanie
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
2/6
Biogen Stock Rockets On Key Patent Win — Is It Time To Buy Shares? [Investor's Business Daily]
10.5%
3/4 PTC Therapeutics, Inc. (NASDAQ: PTCT) had its "hold" rating re-affirmed by analysts at Barclays PLC. They now have a $51.00 price target on the stock. 9.3%
10/29 PTC Therapeutics' (PTCT) CEO Stuart Peltz on Q3 2019 Results - Earnings Call Transcript [Seeking Alpha] 7.9%
5/8 PTC Therapeutics to Participate at Upcoming Investor Conferences 7.9%
3/18 Form 4 PTC THERAPEUTICS, INC. For: Mar 16 Filed by: SCHMERTZLER MICHAEL 6.2%
6/17 PTC Therapeutics, Inc. (NASDAQ: PTCT) was downgraded by analysts at ValuEngine from a "strong-buy" rating to a "buy" rating. 5.9%
3/18 Form SEC STAFF LETTER PTC THERAPEUTICS, INC. 5.7%
10/2 Risdiplam Spinal Muscular Atrophy Data Demonstrating Continued Benefit Presented at World Muscle Society Congress 5.6%
3/30 PTC Therapeutics, Inc. (NASDAQ: PTCT) was downgraded by analysts at TheStreet from a "c-" rating to a "d" rating. 5.5%
4/17 PTC Therapeutics Announces New Leadership Appointments 4.8%
3/4 PTC Therapeutics, Inc. (NASDAQ: PTCT) had its "hold" rating re-affirmed by analysts at Barclays PLC. They now have a $51.00 price target on the stock. 9.3%
10/29 PTC Therapeutics' (PTCT) CEO Stuart Peltz on Q3 2019 Results - Earnings Call Transcript [Seeking Alpha] 7.9%
5/8 PTC Therapeutics to Participate at Upcoming Investor Conferences 7.9%
3/18 Form 4 PTC THERAPEUTICS, INC. For: Mar 16 Filed by: SCHMERTZLER MICHAEL 6.2%
6/17 PTC Therapeutics, Inc. (NASDAQ: PTCT) was downgraded by analysts at ValuEngine from a "strong-buy" rating to a "buy" rating. 5.9%
3/18 Form SEC STAFF LETTER PTC THERAPEUTICS, INC. 5.7%
10/2 Risdiplam Spinal Muscular Atrophy Data Demonstrating Continued Benefit Presented at World Muscle Society Congress 5.6%
3/30 PTC Therapeutics, Inc. (NASDAQ: PTCT) was downgraded by analysts at TheStreet from a "c-" rating to a "d" rating. 5.5%
4/17 PTC Therapeutics Announces New Leadership Appointments 4.8%
TOP News Decliners
3/16
PTC Therapeutics Announces Management Change
-19.5%
3/11 PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) -11.4%
9/17 PTC Therapeutics Announces Proposed Public Offering of Common Stock -11.3%
4/29 PTC Therapeutics Q1 2020 Earnings Preview [Seeking Alpha] -9.4%
3/2 Form 8-K PTC THERAPEUTICS, INC. For: Mar 02 -5.8%
4/30 Q1/2020 3/31/2020 EPS -1.810 ZacksConsensus -1.080 ActVsEst (0.730) - Miss -5.7%
9/30 PTC Therapeutics, Inc. (NASDAQ: PTCT) was given a new $62.00 price target on by analysts at Citigroup Inc. They now have a "buy" rating on the stock. -4.7%
8/5 PTC Therapeutics Expands Presence in New Jersey by Securing State-of-the-Art Biologics Facility -4.6%
1/13 PTC Therapeutics Provides Corporate Update and Highlights Pipeline Progress at 2020 J.P. Morgan Healthcare Conference -4.2%
6/13 Form 8-K PTC THERAPEUTICS, INC. For: Jun 12 -4.1%
3/11 PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) -11.4%
9/17 PTC Therapeutics Announces Proposed Public Offering of Common Stock -11.3%
4/29 PTC Therapeutics Q1 2020 Earnings Preview [Seeking Alpha] -9.4%
3/2 Form 8-K PTC THERAPEUTICS, INC. For: Mar 02 -5.8%
4/30 Q1/2020 3/31/2020 EPS -1.810 ZacksConsensus -1.080 ActVsEst (0.730) - Miss -5.7%
9/30 PTC Therapeutics, Inc. (NASDAQ: PTCT) was given a new $62.00 price target on by analysts at Citigroup Inc. They now have a "buy" rating on the stock. -4.7%
8/5 PTC Therapeutics Expands Presence in New Jersey by Securing State-of-the-Art Biologics Facility -4.6%
1/13 PTC Therapeutics Provides Corporate Update and Highlights Pipeline Progress at 2020 J.P. Morgan Healthcare Conference -4.2%
6/13 Form 8-K PTC THERAPEUTICS, INC. For: Jun 12 -4.1%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: